About Emeritus (NYSE:ESC)
Emeritus Corporation (Emeritus) is engaged in operations of senior living communities in the United States. The Company owns and operates a portfolio of communities providing services to its residents, including independent living, assisted living, specialized memory care, and, to a lesser extent, skilled nursing care. The Company provides a variety of supportive living services in a professionally staffed environment that enables seniors to live with dignity and independence. During the year ending December 31, 2012, the Company added home healthcare to its service offerings, through its acquisition of Florida-based Nurse on Call, Inc. (NOC). As of December 31, 2012, the Company operated 483 senior living communities in 45 states. The communities consisted of approximately 43,000 residential rooms or suites (collectively units) with a resident capacity for approximately 50,100 residents.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Facilities
- Symbol: NYSE:ESC
- CUSIP: 29100510
- Web: N/A
- Trailing P/E Ratio:
- Foreward P/E Ratio: 13.07
- P/E Growth:
Frequently Asked Questions for Emeritus (NYSE:ESC)
What is Emeritus' stock symbol?
Emeritus trades on the New York Stock Exchange (NYSE) under the ticker symbol "ESC."
Who are some of Emeritus' key competitors?
Some companies that are related to Emeritus include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Illumina (ILMN), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), VCA (WOOF), Bio-Rad Laboratories (BIO), NMC Health PLC (NMC), Valeant Pharmaceuticals Intl (VRX), Catalent (CTLT), PRA Health Sciences (PRAH), Health Net (HNT), Patheon NV (PTHN), Mediclinic International PLC (MDC) and Puma Biotechnology (PBYI).
How do I buy Emeritus stock?
Shares of Emeritus can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Emeritus' stock price today?
MarketBeat Community Rating for Emeritus (NYSE ESC)MarketBeat's community ratings are surveys of what our community members think about Emeritus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Emeritus stock can currently be purchased for approximately $33.46.
Consensus Ratings for Emeritus (NYSE:ESC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Emeritus (NYSE:ESC)
Analysts' Ratings History for Emeritus (NYSE:ESC)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Emeritus (NYSE:ESC)Earnings History by Quarter for Emeritus (NYSE ESC)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/1/2013||Q2 2013||($0.48)||($0.66)||$477.38 million||$475.90 million||View||N/A|
|5/2/2013||Q1 2013||($0.56)||($0.88)||$464.96 million||$472.36 million||View||N/A|
|2/28/2013||Q4 2012||($0.44)||$0.40||$403.45 million||$412.10 million||View||N/A|
|11/5/2012||Q312||($0.31)||($0.30)||$337.76 million||$381.12 million||View||N/A|
Earnings Estimates for Emeritus (NYSE:ESC)
Current Year EPS Consensus Estimate: $2.18 EPS
Next Year EPS Consensus Estimate: $2.56 EPS
Dividend History for Emeritus (NYSE:ESC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Emeritus (NYSE:ESC)Insider Trades by Quarter for Emeritus (NYSE:ESC)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/29/2014||Claro Budgie Bautista Amparo||EVP||Sell||31,865||$31.22||$994,825.30|| |
|5/29/2014||James C A Hyatt||COO||Sell||130,690||$31.27||$4,086,676.30|| |
|5/29/2014||Robert C Bateman||CFO||Sell||155,512||$31.09||$4,834,868.08|| |
|5/29/2014||Susan Coppola||SVP||Sell||1,874||$31.30||$58,656.20|| |
|3/4/2014||Melanie Cobb Werdel||EVP||Sell||40,000||$32.00||$1,280,000.00|| |
|3/3/2014||James Hyatt||COO||Sell||14,038||$31.72||$445,285.36|| |
|3/3/2014||Melanie Cobb Werdel||EVP||Sell||8,923||$31.72||$283,037.56|| |
|2/21/2014||Claro Budgie Bautista Amparo||EVP||Sell||30,000||$29.50||$885,000.00|| |
|2/21/2014||James Hyatt||COO||Sell||20,000||$29.50||$590,000.00|| |
|5/14/2013||Jayne E Sallerson||EVP||Sell||25,750||$26.79||$689,842.50|| |
|5/14/2013||John Anthony Cincotta||SVP||Sell||18,950||$26.85||$508,807.50|| |
|5/13/2013||Christopher M Belford||SVP||Sell||33,000||$26.61||$878,130.00|| |
|5/13/2013||Claro Budgie Bautista Amparo||EVP||Sell||8,750||$27.03||$236,512.50|| |
|5/13/2013||James C A Hyatt||COO||Sell||34,427||$26.96||$928,151.92|| |
Headline Trends for Emeritus (NYSE:ESC)
Latest Headlines for Emeritus (NYSE:ESC)
Emeritus (ESC) Chart for Monday, October, 16, 2017